Back to 
Loring Wolcott & Coolidge Fiduciary Advisors LLP
Loring Wolcott & Coolidge Fiduciary Advisors LLP
TEVA
3 quarters
Position history for Loring Wolcott & Coolidge Fiduciary Advisors LLP's holdings in Teva Pharmaceutical Industries Limited
No. Loring Wolcott & Coolidge Fiduciary Advisors exited its TEVA (Teva Pharmaceutical Industries) position in Q3 2023. Its Q2 2023 13F listed 300 shares worth $2,259. Loring Wolcott & Coolidge Fiduciary Advisors first reported TEVA in Q1 2023 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$2,655
Total Shares Change
-300
Quarter-by-Quarter History
Other major holders of TEVA: BlackRock, Inc., Capital Research Global Investors